stock
DNTH · Dianthus Therapeutics, Inc. /DE/
What Dianthus Therapeutics, Inc. /DE/ reports to the SEC, read from its filings.
Open in the appPrice
The live DNTH price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on DNTH.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 55,934,378 as of 2026-08-03 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- -16.4%
- ROA
- -15.8%
Health
- Current ratio
- 26.1x
- Debt/equity
- —
Deep value
- NCAV
- $856.29M
- NCAV per share
- $15.31
- Price/NCAV
- Locked
- NNWC
- $69.38M
- NNWC per share
- $1.24
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | — | —Gross profit: unreported by this company. | -$61.48M | -$50.22M | 10-Q filed 2026-08-04 |
| 2026-03-31 | — | —Gross profit: unreported by this company. | -$46.53M | -$40.83M | 10-Q filed 2026-08-04 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $284,000 | —Gross profit: unreported by this company. | -$69.54M | -$64.43M | DEF 14A filed 2026-04-09 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $396,000 | —Gross profit: unreported by this company. | -$40.29M | -$36.77M | 10-Q filed 2025-11-05 |
| 2025-06-30 | $193,000 | —Gross profit: unreported by this company. | -$34.93M | -$31.63M | 10-Q filed 2026-08-04 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-03-31 | $1.16M | —Gross profit: unreported by this company. | -$33.18M | -$29.51M | 10-Q filed 2026-08-04 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $1.33M | —Gross profit: unreported by this company. | -$31.92M | -$28.44M | DEF 14A filed 2026-04-09 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $2.17M | —Gross profit: unreported by this company. | -$29.90M | -$25.17M | 10-Q filed 2025-11-05 |
- Assets
- $1.21B
- Equity
- $1.17B
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $2.04M | -$177.93M | -$162.34M | — |
| 2024-12-31 | $6.24M | -$101.86M | -$84.97M | — |
| 2023-12-31 | $2.83M | -$48.17M | -$43.55M | — |
| 2022-12-31 | $6.42M | -$29.70M | -$28.48M | -$29.38M |
| 2021-12-31 | $1.48M | -$13.09M | -$13.11M | -$11.17M |
| 2020-12-31 | — | -$78.70M | -$74.94M | -$64.42M |
| 2019-12-31 | $0 | -$82.97M | -$76.77M | -$60.16M |
| 2018-12-31 | $0 | -$59.96M | -$57.52M | -$49.56M |
| 2017-12-31 | $0 | -$35.73M | -$35.49M | -$24.46M |
| 2016-12-31 | $0 | -$9.27M | -$9.43M | -$6.67M |
Company filings
since Fri Sep 18 · 2 offering filings in 12 months
events
5% owners ()
Sirenia Capital Management LP
Stake update
Wellington Management Group LLP
Passive stake
T. Rowe Price Investment Management, Inc.
Stake update
T. Rowe Price Investment Management, Inc.
Passive stake
BlackRock, Inc.
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
CARR EDWARD
CHIEF ACCOUNTING OFFICER
Sale$2,027,646Sep 18, 4:36 PM ET
Randhawa Simrat
EVP, Head of R&D
Sale$2,460,690Sep 3, 4:30 PM ET
Read Simon
Director
Sale$326,554Aug 19, 6:02 PM ET
McGeorge Anne
Director
Sale$844,822Aug 11, 5:15 PM ET
Read Simon
Director
Sale$304,232Aug 11, 5:10 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
- Polen Capital
Period Tue 30 Jun 2026
0.0%Added
News
Stories that named DNTH, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about DNTH.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on DNTH come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the DNTH board